Co-Authors
This is a "connection" page, showing publications co-authored by Manojit Bhattacharya and Chiranjib Chakraborty.
Connection Strength
7.654
-
Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol. 2020 11; 85:104587.
Score: 0.907
-
A SARS-CoV-2 vaccine candidate: In-silico cloning and validation. Inform Med Unlocked. 2020; 20:100394.
Score: 0.892
-
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020 06; 92(6):618-631.
Score: 0.870
-
Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. mBio. 2021 08 31; 12(4):e0114021.
Score: 0.241
-
Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research. Int J Pept Res Ther. 2021; 27(4):2303-2311.
Score: 0.239
-
From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape. Front Immunol. 2021; 12:679344.
Score: 0.239
-
SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection. Ann Med Surg (Lond). 2021 Jun; 66:102428.
Score: 0.237
-
Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis. Vaccines (Basel). 2021 Jun 04; 9(6).
Score: 0.237
-
Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2. Infect Genet Evol. 2021 09; 93:104951.
Score: 0.237
-
All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently. Aging Dis. 2021 Jun; 12(3):688-690.
Score: 0.237
-
The current second wave and COVID-19 vaccination status in India. Brain Behav Immun. 2021 Aug; 96:1-4.
Score: 0.237
-
COVID-19 vaccine: Challenges in developing countries and India's initiatives. Infez Med. 2021 Mar 01; 29(1):165-166.
Score: 0.233
-
Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2. Arch Med Res. 2021 05; 52(4):362-370.
Score: 0.232
-
SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol. 2021 Feb; 14(2):225-238.
Score: 0.232
-
SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics. Infect Genet Evol. 2021 04; 89:104729.
Score: 0.231
-
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic. Immune Netw. 2021 Feb; 21(1):e5.
Score: 0.231
-
Response to: Status of Remdesivir: Not Yet Beyond Question! Arch Med Res. 2021 01; 52(1):104-106.
Score: 0.226
-
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020; 11:1258.
Score: 0.225
-
COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol. 2020 11; 92(11):2260-2262.
Score: 0.222
-
Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak. Arch Med Res. 2020 10; 51(7):728-730.
Score: 0.221
-
Consider TLR5 for new therapeutic development against COVID-19. J Med Virol. 2020 11; 92(11):2314-2315.
Score: 0.221
-
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res. 2020 08; 51(6):595-597.
Score: 0.221
-
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020 08; 51(6):585-586.
Score: 0.220
-
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm. 2019 Mar 25; 559:360-372.
Score: 0.202
-
The crucial role and regulations of miRNAs in zebrafish development. Protoplasma. 2017 Jan; 254(1):17-31.
Score: 0.164